Coming Soon... The Week in Review #3 Gilead Acquisition - Rallying by Association - Improving on …

Eli Lilly and Company (LLY) and Incyte (INCY) announced that, after discussions with the U.S. Food …

CRISPR Therapeutics (CRSP) and Massachusetts General Hospital Cancer Center (MGHCC) have entered into a two-year research collaboration and license …

The Week in Review #2 The Fairest Upgrades of the Week - Some analysts gave a generous …

New Discoveries in Neurodegenerative Diseases  Everyday is another day that can totally differ from the previous …

About Our New Section On Sunday, August 20, 2017 we will post our first “The Week …

EXELIXIS Exelixis’ (EXEL) shareholders know well how good are the firm’s announced financial results for the …

Prohost Letter #412 Part 3 GLIOBLASTOMA - Is There Hope? Senator John McCain was diagnosed with a …

Prohost Letter #412 Part 2 Living Breakthroughs in The Making - Understanding the origin of diseases …

It took only a few months after the dosing stages of NKTR-358 in in a Phase …